Alkaline phosphatase [orthophosphoric-monoester phosphohydrolase (alkalime pH optimum), EC 3.1.3.11
gen-stimulated human blood lymphocytes, in murine lymph nodes, and pig thymus (even after mitogen stimulation), and in blast cells of acute myeloid leukemic patients.
The appearance of N-alkaline phosphatase only in certain types of proliferating lymphocytes and in the sera of patients with lymphoproliferative disorders may be exploited as a cell marker and as a diagnostic tool.
Concomitantly with neoplastic transformation, alterations of certain enzyme activities are known to occur (1, 2) . In spite of the fact that the biological significance of these alterations in most cases is unknown, they can be exploited as convenient markers because they can be revealed in minute amounts and measured with great accuracy.
Increased alkaline phosphatase activity [APase; orthophosphoric-monoester phosphohydrolase (alkaline pH optimum), EC 3.1.3.1] with unique catalytic properties has been described in mouse organs infiltrated with lymphoma cells (3) (4) (5) (6) . Chronological studies in mice revealed that this enzyme appears in measurable amounts in the thymus prior to the diagnosis of the disease (6) . APase nancies and infectious mononucleosis (7) (8) (9) . This enzyme was designated N-alkaline phosphatase, N-APase.
Studies on the occurrence of the enzyme, its purification from human and murine cells, and its properties are described in the present paper. Aminoethanol was distilled freshly before preparing the buffers. Cysteamine-S-phosphate (CASP) was prepared according to Akerfeldt (22) . All (23) were carried out using 0.01-0.10 ml extracts in 1.0 ml of 0.5 M TrisHCl buffer, pH 9.0, containing 1.0 mM p-NPP as substrate.
MATERIALS AND METHODS
The hydrolysis of p-NPP was followed spectrophotometrically at 400 nm for 10-60 min, taking measurements every minute. The absorbance was plotted versus time, and the velocity, v, of p-nitrophenol production was calculated from the linear part of the curve. The molar absorbance of p-nitrophenol at 400 nm is 18,000. Activity with CASP as substrate was assayed under similar conditions. The amount of cysteamine released by hydrolysis of CASP was measured with the aid of dithionitrobenzoate (0.4 mM) in the reaction mixture, according to the method of Ellman (24) . The release of 5-thio-2-nitrobenzoic acid was measured spectrophotometrically at 412 nm at 2 min intervals up to 60 min. The absorbance was plotted versus time, and from the linear part of the curve the velocity, v, was calculated. The molar absorbance of 5-thio-2-nitrobenzoic acid at 412 nm is 13,600. All enzymatic assays were carried out at room temperature (220).
Aminoethanol-O-phosphate or phosphoserine was also used as a substrate in some experiments. Activity measurements of the extracts were carried out in 0.1 M aminoethanol-CI buffer, pH 9.0, or 0.05 M barbital-Cl buffer, pH 9.0. Inorganic phosphate, one of the reaction products, was determined by the method of King (25) . Aliquots (1.0 Peterson and Chiazze (27) It is apparent that a 100-to 1000-fold purification was achieved by this procedure. The contents of the peak tubes were subjected to polyacrylamide gel electrophoresis (both in the presence and absence of Emulphogene in the gel). After the gels were stained for APase activity, only one band appeared (Fig.  5) .
APase Activity in Lymphoblastoid Cell Lines and Cells of CLL and AML Patients. The identification of N-APase was based on: (a) the ratio, R, of the rate of hydrolysis of p-NPP versus CASP under identical conditions; (b) electrophoretic mobility of APase activity in polyacrylamide gel electrophoresis. In previous studies it was shown that the ratio R of the rate of hydrolysis of two types of substrate (Type I and Type II) from organs of normal mice and sera of normal individuals does not exceed 1.9 (3) (4) (5) (6) (7) (8) (9) . The ratio R for human lymphocytes was found to be 1.20 I 0.1 (calculated from Essentially the same ratio was obtained for mitogen-stimulated cells.
The APase activities of normal and mitogen-stimulated lymphocytes, of human, murine, or porcine origin migrated identically. The mobility remained the same in the presence of Emulphogene in the gel. Thus we concluded that N-APase is absent in these cells and is not induced by mitogen-caused proliferation.
In murine lymphoma cells (YAC) and lymphoblastoid cell lines derived from Burkitt lymphomas (Daudi, Raji, Maku, Seraphina, and Namalva) N-APase comprises 50-90% of total APase activity (Table 2) .
N-APase was found also in two nonlymphoma-derived lymphoblastoid lines: Kaplan and LY28. The N-APase in the Kaplan cells was nearly 100% of the total APase activity. On the other hand, N-APase could not be detected in the K562 cell line (Table 2 ). This cell line was established from a chronic myeloid leukemia patient. The incidence of N-APase in peripheral leukocytes of leukemia patients is shown in Table 3 .
The electrophoretic mobility of the enzyme derived from these lines differed from that of normal lymphocyte APase (Fig.  5) . From (Fig. 3) was subjected to Sephadex G-200 gel filtration. Elution of 1.9 ml per tube was with 0.01 M AE-Cl buffer, pH 8.0, at a flow rate of 1.9 ml/30 min. Absorbance at 280 nm, the protein content in 'g of protein per ml as well, and APase activity are presented. A2so (0-0); protein ,g/ml (o.0 * -3); specific activity (o-----0). Biochemistry: Neumann et al. 1436 Biochemistry: Neumann et al. binding or in catalysis (i.e., protonation) would be expected to give major differences in the catalytic hydrolysis. The lack of such differences is of significance in considering the mechanism of APase action (28) (29) (30) .
The appearance of an enzyme with distinct catalytic properties and electrophoretic mobility does not a priori involve the synthesis of a new protein species with different primary sequence. It may be the result of conformational changes, or different assembly of the subunits, through dissociation-association, allosteric effects, or change in the metal ion(s).
Occurrence of N-APase in certain diseases is not the consequence of the high lymphocyte number in the blood or increased enzyme production in proliferating lymphocytes, but may be connected with the special type of blast transformation, as it was not detected in normal lymphocytes, and mnitogeninduced blast cells.
Cells with both bone-marrow-derived (B) and thymus-derived (T) lymphocyte origin were found to produce N-APase. Burkitt Iymphoma lines are B cells and so are the CLL cells. On the other hand, murine Iymphoma YAC is a T cell line. Preliminary experiments also showed the presence of N-APase in a human T cell line Molt-4 (31) . An important finding which may be of practical importance is that the presence of N-APase distinguished cells of lymphoid origin, as it is absent in myeloid blasts.
